Moderna Inc
NASDAQ:MRNA
Moderna Inc
NASDAQ:MRNA
Price:
107.97 USD
1.69%
Market Closed
Updated:
Apr 27, 2024
Moderna Inc
Revenue
|
Moderna Inc
Revenue Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Moderna Inc
NASDAQ:MRNA
|
Revenue
$6.8B
|
CAGR 3-Years
104%
|
CAGR 5-Years
119%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
Moderna Inc
Revenue Breakdown
Breakdown by Geography
Moderna Inc
Moderna Inc
|
Total Revenue:
6.8B
USD
|
|
Rest Of World:
3.6B
USD
|
|
United States:
1.9B
USD
|
|
Europe:
1.4B
USD
|
Breakdown by Segments
Moderna Inc
Moderna Inc
|
Total Revenue:
6.8B
USD
|
|
Net Product Sales:
6.7B
USD
|
|
Other Revenue:
177m
USD
|
|
Grant Revenue:
94m
USD
|
|
Collaboration Revenue:
83m
USD
|
See Also
What is Moderna Inc's Revenue?
Revenue
6.8B
USD
6.8B
USD
Based on the financial report for Dec 31, 2023, Moderna Inc's Revenue amounts to 6.8B USD.
What is Moderna Inc's Revenue growth rate?
Revenue CAGR 5Y
119%
119%
Over the last year, the Revenue growth was -64%. The average annual Revenue growth rates for Moderna Inc have been 104% over the past three years , 119% over the past five years .
You don't have any saved screeners yet
